[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100313569":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":21,"responsibleParty":39,"collaborators":42,"id":49,"slug":7,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":7,"enrollmentInfo":58,"targetDuration":7,"studyType":61,"phases":7,"briefSummary":62,"conditions":63,"keywords":68,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Wuerzburg University Hospital","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Peter Nordbeck, MD, PhD","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","004993120139181","nordbeck_p@ukw.de",{"name":18,"role":14,"phone":19,"phoneExt":7,"email":20},"Jonas Muentze, MD","004993120139958","muentze_j@ukw.de",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"RECRUITING","Würzburg","Bavaria","97080","Germany",{"type":29,"coordinates":30},"Point",[31,32],9.95121,49.79391,{"lat":32,"lon":31},[35],{"name":36,"role":14,"phone":37,"phoneExt":7,"email":38},"Irina Schumacher","004993120139714","schumacher_i@ukw.de",{"type":11,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PD Dr. Peter Nordbeck","Head Consultant Cardiology and Chief of Electrophysiology",[43,45,47],{"name":44,"class":6},"Competence Network Heart Failure",{"name":46,"class":6},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)",{"name":48,"class":6},"St George's, University of London","100313569",false,"NCT03362164","Evaluation of HEArt invoLvement in Patients With FABRY Disease","Prospective Monocentric Cohort Study to Evaluate Predictors for Heart Failure and Sudden Cardiac Death in Patients With Fabry Disease","HEAL-FABRY","Inclusion Criteria:\n\n* Fabry disease (genetically confirmed)\n* Signed informed consent\n* 18 years and older\n\nExclusion Criteria:\n\n* No informed consent\n* Withdrawal of informed consent","ALL","18 Years",{"count":59,"type":60},650,"ESTIMATED","OBSERVATIONAL","This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.",[64,65,66,67],"Rare Diseases","Fabry Disease","Fabry Disease, Cardiac Variant","Hypertrophic Cardiomyopathy",[69,70,71,72,73],"Fabry","Fibrosis","Dialysis","Stroke","Chronic kidney disease","2022-07-06",{"date":76,"type":77},"2022-07-07","ACTUAL",{"date":79,"type":77},"2001-01",{"date":81,"type":60},"2032-03",{"name":5,"class":6},1]